Significant Accounting Policies - Additional Information (Details) - USD ($) $ in Millions |
12 Months Ended | |||
|---|---|---|---|---|
Jan. 01, 2022 |
Jan. 01, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Fortress Biotech, Inc | ||||
| Percentage of annual equity fee | 2.50% | 2.50% | ||
| Number of common stock shares issued | 2,121,422 | 1,742,449 | 297,490 | 310,625 |
| Research and development | ||||
| Value of common stock shares issued | $ 6.6 | $ 4.6 | ||
| X | ||||||||||
- Definition This element represent that percentage of annual equity fee. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|